~~<i id='DDEC116AAF'><strike id='DDEC116AAF'><tt id='DDEC116AAF'><pre id='DDEC116AAF'></pre></tt></strike></i>~~

Home» comprehensive» hotspot

hotspot

author：hotspot 2025-09-06 05:55:34 Page View：6

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New study raises questions about niacin and heart health
Next article： Wildfire smoke exposes gaps in outdoor worker protections

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

FILE-Myanmar'sleaderAungSanSuuKyi,left,attendsthebilateralmeetingwithChinesePresidentXiJinpingatthep

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

5 shark bites reported on Long Island as officials deploy surveillance drones

2:23SharksspottedinLongIslandledtotheclosureofseveralbeachesinNewYorkCity,inJuly22,2022.LokmanVuralE

WSS

hotspot

hotspot

explore

leisure time

5 shark bites reported on Long Island as officials deploy surveillance drones